XML 36 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Related Party Collaboration Agreement
 12 Months Ended
Dec. 31, 2020
Related Party Collaboration Agreement [Abstract]  
Related Party Collaboration Agreement 12. Related Party Collaboration Agreement

In February 2013, the Company entered into an Exclusive Channel Collaboration Agreement with Precigen, its then majority shareholder, pursuant to which the Company would use Precigen’s technology platforms to develop and commercialize additional bioengineered traits in finfish for human consumption.

The Company agreed to pay Precigen quarterly 16.66% of the gross profits calculated under the terms of the agreement for each developed product. The Company likewise agreed to pay Precigen 50% of quarterly revenue obtained from a sublicensor in the event of a sublicensing arrangement. In addition, the Company would reimburse Precigen for the costs of certain services provided by Precigen. The agreement was terminated in 2020 and no royalties were paid to Precigen during the year.

Total Precigen service costs incurred under the terms of this agreement totaled $0 in 2020 (2019: $218 thousand; 2018: $562 thousand), of which $0 is included in accounts payable and accrued liabilities at December 31, 2020 (2019: $1 thousand), and is included as a component of research and development expense in the Consolidated Statements of Operations and Comprehensive Loss.